Categories: Media Partners

Cardiology and Vascular Healthcare 2019

Globally cardiac and vascular experts have pioneered treatments and continue to make advancements in patient care. Despite advancements in prevention and treatment, sudden cardiac death (SCD) remains a leading cause of mortality and is responsible for approximately half of all deaths from cardiovascular disease. A compelling need to study the underlying causes of the many types of cardiovascular disease and to create new methods of prevention and treatment drives Endling Scientific Merits to organize an international conference on  “Advances and Scientific Merits in Cardiology and Cardiovascular Medicine” at Spain during November18-20, 2019.

The main aim of the conference is to bring research advances aimed at understanding the causes of cardiovascular disease and the translation of this knowledge to improve patient care. The global event with a theme “Nurturing tomorrow’s leaders in Cardiac and Vascular Medicine, Surgery and Research”brings scientists and researchers from academia and industry together to share the newest research ideas and findings in the field of Cardiology and Cardiovascular Medicine

This particular conference programme will consist of full papers, poster sessions and as well as invited plenary talks on cardiology and cardiovascular device, detection, medicine, prevention and research. We cordially invite you to attend the conference and submit your abstracts for presentations, posters etc.

Scientific Sessions:

  • Cardiac Remodelling & Regeneration in pathological conditions
  • Advanced cardiac medications & devices
  • Improved techniques of heart transplantation
  • Advances in Nuclear Cardiology
  • Food, Nutrition & Diet Therapy for Cardiac patients
  • Biomarkers of cardiovascular and brain health
  • Cardiac Nursing: Training, Education & healthcare
  • Cardiac metastases
  • Risk of hypertension and stroke
  • Management of peripheral arterial diseases
  • Pathogenesis of atherosclerosis
  • Genetic risk factor for vascular disease
  • Diabetes and cardiovascular risk factors
  • Incidence of congenital heart disease
  • Relationship of obesity and physical fitness to cardiopulmonary and metabolic function
  • Device-based therapy of cardiac rhythm abnormalities
  • Clinical pharmacology research in cardiovascular diseases
  • Diagnosis and management of pericardial diseases
  • Methods and models of cardiovascular physiology and electrophysiology
  • Cardiovascular angiography and interventions
  • Artificial intelligence in cardiology and cardiovascular healthcare

Website: www.cardiologyesm.com

The Pharma Times News Bureau

Share
Published by
The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

5 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

23 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago